At the beginning of the year, Hardy gained FDA clearance for the CARBA 5 lateral flow test kit for the rapid detection of five of the carbapenemase enzymes involved in Gram negative bacterial resistance to most antibiotics (the “superbugs”).
At the beginning of the year, Hardy gained FDA clearance for the CARBA 5 lateral flow test kit for the rapid detection of five of the carbapenemase enzymes involved in Gram negative bacterial resistance to most antibiotics (the “superbugs”).
Your newsletter is outstanding! Good Humor, incredibly useful information, wisdom and quotes! There is no other like it; I pass it around even to those with non-science backgrounds. Good work Hardy!
Michael J. Kolf R.Ph.
NIH Clinical Center Pharmacy